Tarsons Products Limited (TARSONS.BO)

INR 359.65

(-0.65%)

EBITDA Summary of Tarsons Products Limited

Tarsons Products Limited's latest annual EBITDA in 2023 was 1.11 Billion INR , down -29.38% from previous year.
Tarsons Products Limited's latest quarterly EBITDA in 2024 Q1 was 187.67 Million INR , down -35.54% from previous quarter.
Tarsons Products Limited reported an annual EBITDA of 1.41 Billion INR in 2022, down -12.14% from previous year.
Tarsons Products Limited reported an annual EBITDA of 1.61 Billion INR in 2021, up 47.99% from previous year.
Tarsons Products Limited reported a quarterly EBITDA of 235.6 Million INR for 2023 Q1, down -43.02% from previous quarter.
Tarsons Products Limited reported a quarterly EBITDA of 279.78 Million INR for 2023 Q2, up 18.75% from previous quarter.

Annual EBITDA Chart of Tarsons Products Limited (2023 - 2018)

Historical Annual EBITDA of Tarsons Products Limited (2023 - 2018)

Year	EBITDA	EBITDA Growth
2023	1.11 Billion INR	-29.38%
2022	1.41 Billion INR	-12.14%
2021	1.61 Billion INR	47.99%
2020	1.08 Billion INR	48.81%
2019	734.06 Million INR	-5.52%
2018	776.38 Million INR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	187.67 Million INR	-35.54%
2023 Q1	235.6 Million INR	-43.02%
2023 Q2	279.78 Million INR	18.75%
2023 Q3	261.26 Million INR	-6.62%
2023 FY	- INR	-29.38%
2023 Q4	302.48 Million INR	15.78%
2022 Q2	364.09 Million INR	7.62%
2022 FY	- INR	-12.14%
2022 Q4	413.46 Million INR	37.68%
2022 Q3	300.3 Million INR	-17.52%
2022 Q1	338.3 Million INR	-27.52%
2021 Q2	399.19 Million INR	3.05%
2021 FY	- INR	47.99%
2021 Q1	387.38 Million INR	9.12%
2021 Q3	355.95 Million INR	-10.83%
2021 Q4	466.75 Million INR	31.13%
2020 Q1	130.99 Million INR	0.0%
2020 FY	- INR	48.81%
2020 Q4	355.01 Million INR	9.3%
2020 Q3	324.8 Million INR	0.0%
2019 FY	- INR	-5.52%
2018 FY	- INR	0.0%

Peer EBITDA Comparison of Tarsons Products Limited

Name	EBITDA	EBITDA Difference
Poly Medicure Limited	4.2 Billion INR	73.498%